Publications by authors named "Patrick Mollon"

Claim this Profile
W
Whole-Genome Sequencing Snapshot of Clinically Relevant Carbapenem-Resistant Gram-Negative Bacteria from Wastewater in Serbia.
Ivana Cirkovic, Bruno H Muller, Ana Janjusevic, Patrick Mollon, Valérie Istier

Antibiotics (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial.
Nick Freemantle, Patrick Mollon, Tim Meyer, Ann-Lii Cheng, Anthony B El-Khoueiry

Eur J Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison.
Jörg Trojan, Patrick Mollon, Bruno Daniele, Florence Marteau, Lidia Martín

Adv Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
Robin K Kelley, Patrick Mollon, Jean-Frédéric Blanc, Bruno Daniele, Thomas Yau

Adv Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
Steven R Feldman, Haijun Tian, Isabelle Gilloteau, Patrick Mollon, Meng Shu

BMC Health Serv Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms and Functional Limitations in the First Year Following a Myocardial Infarction: A Qualitative Study.
Chad Gwaltney, Matthew Reaney, Meaghan Krohe, Mona M Martin, Heather Falvey, Patrick Mollon

Patient· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept.
Bruce Strober, Alice B Gottlieb, Bintu Sherif, Patrick Mollon, Isabelle Gilloteau

J Am Acad Dermatol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes, health resource use, and cost in patients with early versus late dual or triple anti-platelet treatment for acute coronary syndrome.
Howard Friedman, Patrick Mollon, Jean Lian, Prakash Navaratnam

Am J Cardiovasc Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey.
Varant Kupelian, Kevin T McVary, Steven A Kaplan, Susan A Hall, Carol L Link, Patrick Mollon

J Urol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals.
Felicitas C Kühne, Jeremy Chancellor, Patrick Mollon, Daniela E Myers, Michael Louie

HIV Clin Trials· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey.
Varant Kupelian, Kevin T McVary, Steven A Kaplan, Susan A Hall, Carol L Link, Patrick Mollon

J Urol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey.
Susan A Hall, Carol L Link, Sharon L Tennstedt, Patrick Mollon, Lalitha Padmanabhan Aiyer

BJU Int· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey.
Varant Kupelian, Kevin T McVary, Michael J Barry, Carol L Link, Raymond C Rosen, Patrick Mollon

Urology· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower urinary tract symptoms and sexual health: the role of gender, lifestyle and medical comorbidities.
Raymond C Rosen, Carol L Link, Michael P O'Leary, Francois Giuliano, Lalitha P Aiyer, Patrick Mollon

BJU Int· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms.
Steven A Kaplan, Claus G Roehrborn, Christopher R Chapple, Raymond C Rosen, Debra E Irwin, Patrick Mollon

BJU Int· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey.
Varant Kupelian, Raymond C Rosen, Carol L Link, Kevin T McVary, Lalitha Padmanabhan Aiyer, Patrick Mollon

J Urol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the cluster: methodological and clinical implications in the Boston Area Community Health survey and EPIC studies.
Raymond C Rosen, Karin S Coyne, David Henry, Carol L Link, Amy Cinar, Patrick Mollon

BJU Int· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis